Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kirkpatrick

Showing results (271-280 of 308) with videos related to

Pageof 31
Sort By:
Clinical Pharmacology in Drug Development|April 30, 2016
PARP activity in peripheral blood lymphocytes as a predictive biomarker for PARP inhibition in tumor tissues - A population pharmacokinetic/pharmacodynamic analysis of rucaparibDiane D Wang, Chunze Li, Wan Sun, et al.
Antimicrobial Agents and Chemotherapy|December 3, 2014
The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicansNathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
International Journal of Molecular Sciences|February 8, 2012
Assessment of Aspergillus fumigatus in guinea pig bronchoalveolar lavages and pulmonary tissue by culture and realtime polymerase chain reaction studiesDennis G Hooper, Vincent E Bolton, John S Sutton, et al.
The Journal of Antimicrobial Chemotherapy|January 14, 2012
Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosisWilliam R Kirkpatrick, Laura K Najvar, Ana C Vallor, et al.
Expert Review of Clinical Pharmacology|June 21, 2016
Transmission pathways and mediators as the basis for clinical pharmacology of painDaniel R Kirkpatrick, Dan M McEntire, Tyler A Smith, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 27, 2026
Pediatric Admissions During the COVID-19 Pandemic in a Hospital With Low Prevalence of SARS-CoV-2Jordon C Mitzelfelt, Kristin C Mara, Jaclyn Whelan, et al.
The American Journal of Medicine|August 4, 1998
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistanceS G Revankar, W R Kirkpatrick, R K McAtee, et al.
Optics Express|June 14, 2025
Micro-drilling hollow-core fiber using image processing for rotational alignmentEleanor A Warrington, Patrick S Salter, William O C Davis, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Standardization of an experimental murine model of invasive pulmonary aspergillosisDonald C Sheppard, John R Graybill, Laura K Najvar, et al.
Antimicrobial Agents and Chemotherapy|October 22, 2014
The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicansNathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
Pageof 31

Showing results (271-280 of 308) with videos related to

Sort By:
Pageof 31
Clinical Pharmacology in Drug Development|April 30, 2016
PARP activity in peripheral blood lymphocytes as a predictive biomarker for PARP inhibition in tumor tissues - A population pharmacokinetic/pharmacodynamic analysis of rucaparibDiane D Wang, Chunze Li, Wan Sun, et al.
Antimicrobial Agents and Chemotherapy|December 3, 2014
The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicansNathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
International Journal of Molecular Sciences|February 8, 2012
Assessment of Aspergillus fumigatus in guinea pig bronchoalveolar lavages and pulmonary tissue by culture and realtime polymerase chain reaction studiesDennis G Hooper, Vincent E Bolton, John S Sutton, et al.
The Journal of Antimicrobial Chemotherapy|January 14, 2012
Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosisWilliam R Kirkpatrick, Laura K Najvar, Ana C Vallor, et al.
Expert Review of Clinical Pharmacology|June 21, 2016
Transmission pathways and mediators as the basis for clinical pharmacology of painDaniel R Kirkpatrick, Dan M McEntire, Tyler A Smith, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 27, 2026
Pediatric Admissions During the COVID-19 Pandemic in a Hospital With Low Prevalence of SARS-CoV-2Jordon C Mitzelfelt, Kristin C Mara, Jaclyn Whelan, et al.
The American Journal of Medicine|August 4, 1998
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistanceS G Revankar, W R Kirkpatrick, R K McAtee, et al.
Optics Express|June 14, 2025
Micro-drilling hollow-core fiber using image processing for rotational alignmentEleanor A Warrington, Patrick S Salter, William O C Davis, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Standardization of an experimental murine model of invasive pulmonary aspergillosisDonald C Sheppard, John R Graybill, Laura K Najvar, et al.
Antimicrobial Agents and Chemotherapy|October 22, 2014
The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicansNathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
Pageof 31